Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 3.21
STAA's Cash to Debt is ranked higher than
75% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. STAA: 3.21 )
STAA' s 10-Year Cash to Debt Range
Min: 0.08   Max: 9.66
Current: 3.21

0.08
9.66
Equity to Asset 0.65
STAA's Equity to Asset is ranked higher than
74% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. STAA: 0.65 )
STAA' s 10-Year Equity to Asset Range
Min: 0.29   Max: 0.81
Current: 0.65

0.29
0.81
F-Score: 4
Z-Score: 10.23
M-Score: -2.56
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -1.91
STAA's Operating margin (%) is ranked higher than
61% of the 294 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.30 vs. STAA: -1.91 )
STAA' s 10-Year Operating margin (%) Range
Min: -37.38   Max: 23.93
Current: -1.91

-37.38
23.93
Net-margin (%) -2.76
STAA's Net-margin (%) is ranked higher than
61% of the 294 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.98 vs. STAA: -2.76 )
STAA' s 10-Year Net-margin (%) Range
Min: -35.56   Max: 21.61
Current: -2.76

-35.56
21.61
ROE (%) -5.55
STAA's ROE (%) is ranked higher than
60% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. STAA: -5.55 )
STAA' s 10-Year ROE (%) Range
Min: -144.72   Max: 26.13
Current: -5.55

-144.72
26.13
ROA (%) -3.22
STAA's ROA (%) is ranked higher than
61% of the 299 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. STAA: -3.22 )
STAA' s 10-Year ROA (%) Range
Min: -44.11   Max: 19.33
Current: -3.22

-44.11
19.33
ROC (Joel Greenblatt) (%) -7.36
STAA's ROC (Joel Greenblatt) (%) is ranked higher than
61% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.48 vs. STAA: -7.36 )
STAA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -136.11   Max: 39.45
Current: -7.36

-136.11
39.45
Revenue Growth (%) -8.80
STAA's Revenue Growth (%) is ranked higher than
58% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. STAA: -8.80 )
STAA' s 10-Year Revenue Growth (%) Range
Min: -12.5   Max: 14.8
Current: -8.8

-12.5
14.8
EBITDA Growth (%) 71.00
STAA's EBITDA Growth (%) is ranked higher than
97% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.40 vs. STAA: 71.00 )
STAA' s 10-Year EBITDA Growth (%) Range
Min: -71.5   Max: 71
Current: 71

-71.5
71
EPS Growth (%) -38.00
STAA's EPS Growth (%) is ranked higher than
50% of the 242 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. STAA: -38.00 )
STAA' s 10-Year EPS Growth (%) Range
Min: -40.5   Max: 18.9
Current: -38

-40.5
18.9
» STAA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

STAA Guru Trades in Q3 2013

Jim Simons 83,872 sh (New)
Steven Cohen Sold Out
» More
Q4 2013

STAA Guru Trades in Q4 2013

Chuck Royce 233,276 sh (New)
Jim Simons 32,100 sh (-61.73%)
» More
Q1 2014

STAA Guru Trades in Q1 2014

Chuck Royce 233,276 sh (unchged)
Jim Simons 31,600 sh (-1.56%)
» More
Q2 2014

STAA Guru Trades in Q2 2014

Chuck Royce 233,276 sh (unchged)
Steven Cohen 109,500 sh (unchged)
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with STAA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 10.29
STAA's P/B is ranked lower than
63% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. STAA: 10.29 )
STAA' s 10-Year P/B Range
Min: 1.38   Max: 17.54
Current: 10.29

1.38
17.54
P/S 5.79
STAA's P/S is ranked lower than
60% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.80 vs. STAA: 5.79 )
STAA' s 10-Year P/S Range
Min: 0.31   Max: 9.81
Current: 5.79

0.31
9.81
EV-to-EBIT -110.09
STAA's EV-to-EBIT is ranked lower than
51% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.48 vs. STAA: -110.09 )
STAA' s 10-Year EV-to-EBIT Range
Min: 114.7   Max: 1063.5
Current: -110.09

114.7
1063.5
Current Ratio 2.95
STAA's Current Ratio is ranked higher than
75% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. STAA: 2.95 )
STAA' s 10-Year Current Ratio Range
Min: 1.06   Max: 3.77
Current: 2.95

1.06
3.77
Quick Ratio 2.08
STAA's Quick Ratio is ranked higher than
75% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. STAA: 2.08 )
STAA' s 10-Year Quick Ratio Range
Min: 0.55   Max: 2.37
Current: 2.08

0.55
2.37

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 31.17
STAA's Price/Net Current Asset Value is ranked higher than
83% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. STAA: 31.17 )
STAA' s 10-Year Price/Net Current Asset Value Range
Min: 6.04   Max: 1731.3
Current: 31.17

6.04
1731.3
Price/Tangible Book 11.11
STAA's Price/Tangible Book is ranked higher than
64% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.39 vs. STAA: 11.11 )
STAA' s 10-Year Price/Tangible Book Range
Min: 0.94   Max: 23.8
Current: 11.11

0.94
23.8
Price/DCF (Projected) 21.17
STAA's Price/DCF (Projected) is ranked higher than
74% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.22 vs. STAA: 21.17 )
STAA' s 10-Year Price/DCF (Projected) Range
Min: 0.9   Max: 84.58
Current: 21.17

0.9
84.58
Price/Median PS Value 1.85
STAA's Price/Median PS Value is ranked higher than
57% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. STAA: 1.85 )
STAA' s 10-Year Price/Median PS Value Range
Min: 0.13   Max: 3.19
Current: 1.85

0.13
3.19
Earnings Yield (Greenblatt) 0.10
STAA's Earnings Yield (Greenblatt) is ranked lower than
56% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. STAA: 0.10 )
STAA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 0.9
Current: 0.1

0.1
0.9
Forward Rate of Return (Yacktman) -0.73
STAA's Forward Rate of Return (Yacktman) is ranked higher than
70% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.14 vs. STAA: -0.73 )
STAA' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -5.2   Max: -0.9
Current: -0.73

-5.2
-0.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:SR3.Germany
STAAR Surgical was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company designs, develops, manufactures and sells implantable lenses for the eye. The Company is a maker of lenses used worldwide in corrective surgery, and it also make lenses for use in surgery that treats cataracts. All of the lenses it make are foldable, which permits the surgeon to insert them through a small incision during minimally invasive surgery. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company operates its global administrative headquarters and a manufacturing facility in Monrovia, California. The Monrovia manufacturing facility principally makes Collamer and silicone IOLs and injector systems for IOLs and ICLs. STAAR also currently manufactures the raw material for Collamer lenses (both IOLs and ICLs) and the AquaFlow Device (for the treatment of glaucoma) in a facility in Aliso Viejo, California. It operates an administrative, manufacturing and distribution facility in Nidau, Switzerland under its wholly owned subsidiary, STAAR Surgical AG. The Nidau manufacturing facility makes all of STAAR's Visian ICL products and also manufactures the AquaFlow Device. After consolidating manufacturing in Monrovia, California, STAAR plans to continue to maintain an administrative and distribution facility in Switzerland. It operates administrative, manufacturing and distribution facilities in Japan under its wholly owned subsidiary, STAAR Japan Inc. STAAR Japan's administrative facility is located in Shin-Urayasu and its manufacturing and distribution facility is located in Ichikawa City. STAAR currently assembles all of its preloaded IOL injectors at the Ichikawa City facility. After consolidating manufacturing in Monrovia, California, the Company plans to continue to maintain administrative and distribution facilities in Japan. The Company is subject to periodic inspection by the FDA for compliance with the FDA's quality system regulations and requirements, such as restrictions on advertising and promotion.
» More Articles for STAA

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlight: MHR, DISCA, BCR, STAA, PEGA, IDXX Aug 22 2011 
STAAR Surgical Generates Cash From Operations During Second Quarter Aug 03 2009 

More From Other Websites
Nasdaq stocks posting largest percentage decreases Aug 28 2014
STAAR Surgical To Present At The Baird 2014 Health Care Conference Aug 28 2014
SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against STAAR Surgical... Aug 27 2014
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action... Aug 25 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in STAAR... Aug 25 2014
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against STAAR Surgical... Aug 14 2014
INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the... Aug 14 2014
SHAREHOLDER ALERT: Brower Piven Encourages Investors With Losses Over $100,000 In STAAR Surgical... Aug 12 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against STAAR Surgical... Aug 08 2014
STAAR SURGICAL CO Financials Aug 08 2014
STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences Aug 07 2014
INVESTOR ALERT: Class Action Lawsuit Against STAAR Surgical Company Announced by Law Offices of... Aug 07 2014
STAAR Surgical To Present At Wedbush And Canaccord Investor Conferences Aug 07 2014
EQUITY ALERT: Rosen Law Firm Reminds STAAR Surgical Company Investors of Important Class Action... Aug 05 2014
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 01 2014
STAAR Surgical Reports 10% Second Quarter Revenue Growth Jul 31 2014
5:37 pm STAAR Surgical --CORRECTION-- misses by $0.01, reports revs in-line; guides 2H14 above... Jul 31 2014
STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jul 31 2014
STAAR Surgical Co Earnings Call scheduled for 5:00 pm ET today Jul 31 2014
STAAR SURGICAL CO Files SEC form 10-Q, Quarterly Report Jul 31 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK